49 Benign Thyroid Disease • Multinodular, simple (smoothly enlarged), retrosternal goitres • Increased where iodine is deficient • Long-standing may develop clinical or subclinical thyrotoxicosis • Symptoms Neck swelling Dyspnea Dysphagia Choking Stridor • Ethnicity No racial predilection exists • Incidence Multinodular goitres is one of the common endocrine conditions, affecting 500 million people worldwide • Sex F:M 5:1 In the Wickham study, 26% of women had a goitre compared with 7% of men Thyroid nodules are less frequent in men than in women, but when found, they are more likely to be malignant • Age The frequency of goitres decreases with advancing age The decrease in frequency differs from the incidence of thyroid nodules, which increases with advancing age • Aetiology Iodine deficiency Autoimmune thyroiditis—Hashimoto or postpartum thyroiditis Excess iodine (Wolff–Chaikoff effect) or lithium ingestion, which decrease release of thyroid hormone Goitrogens, e.g., propylthiouracil, lithium, carbamazepine Stimulation of thyroid stimulating hormone (TSH) receptors by TSH from pituitary tumours, pituitary thyroid hormone resistance, gonadotropins, and/or thyroid-stimulating immunoglobulins Inborn errors of metabolism causing defects in biosynthesis of thyroid hormones Exposure to radiation Deposition diseases Thyroid hormone resistance Subacute thyroiditis (de Quervain thyroiditis) Silent thyroiditis Riedel thyroiditis Infectious agents – Acute suppurative—bacterial – Chronic—mycobacteria, fungal, and parasitic Granulomatous disease Thyroid malignancy • Physiological Puberty Pregnancy oral contraceptive pill (OCP) • Pathological—iodine deficiency • Medical treatments Radioactive iodine: – Up to 50% reduction in goitre volume – Risks include: hypothyroidism, Graves – Contraindicated in pregnant women or women wanting to get pregnant within 1 year of treatment Suppression therapy: – Thyroxine administration decreases TSH leading to a reduction in volume – Risks include: thyrotoxicosis, cardiac arrythmias, thyroid increases to pretreatment size on cessation of thyroxine, osteopenia in long-term thyroxine use Antithyroid medication: – Indicated for thyrotoxic patients, e.g., propylthiouracil (side effects: rash and agranulocytosis) – 50% relapse rate • Retrosternal goitre May present with dyspnea, stridor that is positional/nocturnal, or coincidentally on chest X-ray with shadowing in upper mediastinum – Inability to palpate below it – Dullness to percussion over sternum – May only be a small cervical component – Pemberton sign: facial flushing after raising both arms in the air due to compression of jugular veins by thyroid Investigations: – CT scan good for demonstrating retrosternal extent ± tracheal compression – Spirometry Treatment: – Conservative (if medically unfit) – Surgery: most can be removed via cervical route (unless below aortic arch) may need cardiothoracic input ± sternotomy – Increasing role of radioactive iodine in euthyroid retrosternal goitre safe to use down to a tracheal diameter of 1 cm • Graves disease Most common One or more: – Thyrotoxicosis – Goitre – Eye signs: lid lag, exophthalmos, chemosis – Skin signs: acropachy, pretibial myxedema Autoimmune with thyroid antibodies 15% family history F>M 5:1; middle ages Treatments: – Radioactive iodine – Antithyroid drugs, e.g., carbimazole or propylthiouracil – Block and replace: antithyroid drugs full dose + thyroxine to replace thyroid function – Surgery • Solitary toxic nodule • Long-standing MNGs (Plummer disease) • 50% of patients relapse on carbimazole/propylthiouracil—may request thyroidectomy • When considering surgery need to achieve euthyroid state preop with antithyroid medication, β-blockade and Lugol iodine (up to 2 weeks preop)
49.1 Clinical Features
49.2 Epidemiology
49.3 Simple Goitres (Fig. 49.1)
49.3.1 Toxic Goitres
49.3.2 Clinical Features
49.3.3 Treatment
< div class='tao-gold-member'>
Stay updated, free articles. Join our Telegram channel
Benign Thyroid Disease
Only gold members can continue reading. Log In or Register a > to continue